Every Form 4 that Quipt Home Medical Corp. (QIPT) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow QIPT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full QIPT filings page.
Quipt Home Medical director Brian Joseph Wessel reported dispositions of his equity in connection with the company’s acquisition. On March 16, 2026, all of his 75,000 stock options with a $4.99 exercise price and 116,854 common shares held directly were disposed of to the issuer under a plan of arrangement that paid $3.65 per share in cash for each common share. An additional 98,875 common shares were disposed of from the B & E Wessel Family Trust, which holds the shares for the benefit of Brian and Eliana Wessel and their children; Mr. Wessel disclaims beneficial ownership of these trust-held securities. Footnotes state that, at the effective time of the arrangement, all issued and outstanding common shares were transferred to the purchasers for cash and all vested options were surrendered for a cash payment equal to the excess, if any, of $3.65 over the option exercise price, while options with exercise prices at or above $3.65 and 80,406 restricted share units were cancelled without consideration.
Quipt Home Medical Corp. Chief Accounting Officer Thomas Roehrig reported disposing of all his reported equity interests in connection with the company’s cash acquisition. He returned stock options covering 50,000, 50,000 and 30,000 common shares with exercise prices of $2.45, $6.27 and $6.14 per share to the issuer. He also disposed of 173,000 common shares at $3.65 per share to the purchaser under a plan of arrangement that cashed out all outstanding common shares at $3.65 per share. Following these transactions, the filing shows no remaining shares or options held.
Quipt Home Medical Corp. Chief Compliance Officer Miles Mark Alan reported dispositions of both common shares and stock options tied to the company’s go‑private transaction. On March 16, 2026, he disposed of 110,000 common shares at US$3.65 per share to the acquiring purchasers under a plan of arrangement.
He also disposed of 57,500 stock options, with exercise prices of US$1.11, US$6.27, and US$6.14, which were treated in cash in line with the arrangement terms. Following these transactions, the filing shows he holds no remaining Quipt common shares or stock options.
Quipt Home Medical Corp. director Mark Alan Greenberg reported disposing of his equity position in connection with the company’s plan of arrangement. On March 16, 2026, he transferred 435,457 common shares at $3.65 per share to the purchaser and surrendered stock options for 488,750 common shares back to the issuer. Under the arrangement terms, all Quipt common shares were acquired for $3.65 in cash, certain restricted share units totaling 92,862 were forfeited, and options with exercise prices at or above $3.65 were cancelled without consideration.
Quipt Home Medical Corp. executive Patrick Dennis Gamble has fully exited his equity position as part of the company’s cash acquisition. On March 16, 2026, he disposed of 60,057 Common Shares at US$3.65 per share in a disposition to the issuer under a plan of arrangement.
He also surrendered 15,000 stock options with a US$6.14 exercise price, which were cancelled for no consideration because the exercise price was at or above the US$3.65 cash deal value. Following these transactions, the filing shows he holds no remaining shares or options.
Quipt Home Medical Corp.’s President and CEO Gregory John Crawford reported that all of his equity in the company was cashed out in connection with a change-of-control transaction. Under a court-approved plan of arrangement, all common shares were transferred to purchasers for US$3.65 per share in cash.
Crawford disposed of 3,351,196 common shares held directly at US$3.65 per share, plus additional shares held indirectly by his spouse and by the Gregory J. Crawford Family 2017 Children's Trust, for which he disclaims beneficial ownership. A stock option covering 75,000 shares with a US$6.27 exercise price was also surrendered to the issuer under the arrangement’s option treatment provisions. Following these transactions, the filing shows no remaining shares or options held.
Quipt Home Medical Corp. director Kevin A. Carter disposed of his remaining equity position in connection with the company’s acquisition. On March 16, 2026, all 201,160 of his Common Shares were transferred under a plan of arrangement for a cash payment of US$3.65 per share. In addition, 5,625 stock options with a US$6.27 exercise price were surrendered to the issuer and cancelled with no cash consideration, consistent with the arrangement terms that options priced at or above US$3.65 receive no payment. Following these transactions, Carter no longer holds Quipt common shares or related options.
Quipt Home Medical Corp. executive vice president of operations David Bachelder reported disposing of his equity positions in connection with the company’s cash acquisition. He surrendered 80,000 stock options, with exercise prices of US$4.99 and US$6.14, back to the issuer and disposed of 22,156 common shares at US$3.65 per share, all coded as dispositions to the issuer.
Under the arrangement, all Quipt common shares were transferred to the purchasers for US$3.65 in cash, while restricted share units were cashed out at the same price less taxes. Options became fully vested and were surrendered for any intrinsic value above US$3.65, with underwater options canceled for no consideration. Following these transactions, Bachelder no longer reports any remaining shares or options.
Quipt Home Medical Corp.’s Chief Financial Officer Hardik Mehta reported dispositions of his equity as the company was acquired for US$3.65 per common share under a plan of arrangement. All issued and outstanding shares, other than any properly dissenting shares, were transferred to the purchasers for cash.
The filing shows 60,000 stock options disposed to the issuer and 366,471 common shares disposed at US$3.65 per share, leaving zero direct holdings reported. An additional 884,199 common shares held by the SK Family Trust for the benefit of Mr. Mehta’s children were also disposed at US$3.65 per share; Mr. Mehta disclaims beneficial ownership of those securities.
Quipt Home Medical Corp.'s President and CEO Gregory John Crawford, who also serves as a director, reported exercising stock options for 581,000 common shares on 12/05/2025 at an exercise price of $1.11 per share, based on converting a C$1.50 exercise price at a 0.74 exchange rate.
After these transactions he directly owns 3,351,196 common shares. Additional holdings include 22,500 common shares held by his spouse and 1,216,832 common shares held by a family trust for his children, for which he disclaims beneficial ownership. Options corresponding to 581,000 of his shares and 2,500 of his spouse’s shares, expiring on 04/09/2028, were fully exercised in these moves, leaving no remaining options from these specific grants.